Cerivastatin-induced rhabdomyolysis

被引：31

作者：

Rodríguez, ML ^{[1
]}

Mora, C ^{[1
]}

Navarro, JF ^{[1
]}

机构：

[1] Hosp Nuestra Senor de Candelaria, Santa Cruz de Tenerife 38010, Spain

来源：

ANNALS OF INTERNAL MEDICINE | 2000年 / 132卷 / 07期

关键词：

D O I：

10.7326/0003-4819-132-7-200004040-00031

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：598 / 598

页数：1

共 5 条

[1]

BISCHOLL H, 1998, AM J CARDIOL S, V82, P18

[2] Cerivastatin [J].

McClellan, KJ ;

Wiseman, LR ;

McTavish, D .

DRUGS, 1998, 55 (03) :415-420

[3] Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients [J].

Mück, W ;

Mai, I ;

Fritsche, L ;

Ochmann, K ;

Rohde, G ;

Unger, S ;

Johne, A ;

Bauer, S ;

Budde, K ;

Roots, I ;

Neumayer, HH ;

Kuhlmann, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) :251-261

[4] Cerivastatin in primary hyperlipidemia: A multicenter analysis of efficacy and safety [J].

Stein, E .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) :40J-46J

[5] Extending therapy options in treating lipid disorders - A clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor [J].

Stein, EA .

DRUGS, 1998, 56 (Suppl 1) :25-31

← 1 →